[EN] N-SUBSTITUTED 4-(5-PHENYL-1,3,4-OXADIAZOL-2-YL)ANILINE FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION<br/>[FR] 4-(5-PHÉNYL-1,3,4-OXADIAZOL-2-YL)ANILINE N-SUBSTITUÉE POUR LE TRAITEMENT ET LA PROPHYLAXIE D'UNE INFECTION PAR LE VIRUS DE L'HÉPATITE B
申请人:HOFFMANN LA ROCHE
公开号:WO2022112139A1
公开(公告)日:2022-06-02
The present invention provides novel compounds having the general formula (I) wherein R1to R3are as described herein, or a pharmaceutically acceptable salt thereof, compositions including the compounds and methods of using the compounds.
本发明提供了具有一般式(I)的新化合物,其中R1到R3如本文所述,或其药学上可接受的盐,包括这些化合物的组合物和使用这些化合物的方法。